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Abstract:   The main purpose of this study was to find out the causative agents of urinary tract 
infections (UTI) and their culture and antibiotic sensitivity in patients visiting Tribhuvan Universi-
ty and Teaching Hospital (TUTH).  A retrospective study conducted among 155 patients, aged 
from 25-50 years with culture-positive UTI, who visited TUTH from 1st April 2017 to 30th Sep-
tember 2017. A culture of midstream urine was done to find out causative agents and their anti-
biotic sensitivity performed. Data were evaluated using Microsoft Excel 2016. Female were 
more affected than males. Escherichia coli (E. coli) was the most common microbes causing 
UTI in 53% patients. Most of the isolates on culture were Multi-Drug Resistant (MDR) strains to 
comprise 52%. Of the total gram-negative organisms, 33.9% were Extended Spectrum β-
lactamase (ESBL) producers, and 3.57% were Metallo β-lactamase (MBL) producers. 29.41% 
of Staphylococcus were resistant to methicillin. E.coli is the most common organism causing 
UTI among adults. Multidrug-resistant has appeared alarming with resistant to most of the first 
line antibiotics.  
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INTRODUCTION 
Microbial invasion of any tissue from 
renal cortex to urethral meatus is considered 
as Urinary Tract Infection (UTI) (Obiogbolu et 
al., 2009). About  10% of population experi-
ence UTI in their lifetime is one of the most 
common infectious disease (Farajnia et 
al.,2009). UTI is more common in females than 
males and rarely occurs in men without any 
functional or anatomical abnormalities along 
urinary tract (Stamm et al., 2001). Sex 
(distance between anus and urethral mea-
tus,shorter in female), age (low concentration 
of lactobacillus in elder female), personal hy-
giene, pregnancy, use of birth control pills, im-
mune-suppressive conditions, diabetes, instru-
mentation of urinary tract are some of the risk 
factors predisposing to UTI (Flores-Mireless et 
al., 2015). UTI can be classified as sympto-
matic or asymptomatic, complicated or uncom-
plicated and upper or lower urinary tract infec-
tions (Behzadi et al., 2010).  
Microbial invasion of any tissue from 
renal cortex to urethral meatus is considered 
as Urinary Tract Infection (UTI) (Obiogbolu et 
al., 2009). About  10% of population experi-
ence UTI in their lifetime is one of the most 
common infectious disease (Farajnia et 
al.,2009). UTI is more common in females than 
males and rarely occurs in men without any 
functional or anatomical abnormalities along 
urinary tract (Stamm et al., 2001). Sex 
(distance between anus and urethral mea-
tus,shorter in female), age (low concentration 
of lactobacillus in elder female), personal hy-
giene, pregnancy, use of birth control pills, im-
mune-suppressive conditions, diabetes, instru-
mentation of urinary tract are some of the risk 
factors predisposing to UTI (Flores-Mireless et 
al., 2015). UTI can be classified as sympto-
matic or asymptomatic, complicated or uncom-
plicated and upper or lower urinary tract infec-
tions (Behzadi et al., 2010). Therefore, treat-
ment of UTI is started empirically in the majori-
ty of cases using first-line antibiotics like Tri-
methoprim-Sulphamethoxazole (TMP/SMX), 
fluoroquinolones, Third generation cephalo-
sporin’s (Shrestha et al., 2007).  For proper 
treatment, it is always mandatory to know 
about the prevailing pathogens and their pat-
tern of sensitivity and resistant towards the 
empirical antibiotics used.  
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This study might be useful for the health 
care providers in Nepal to understand current 
scenario of UTI and rational use of antibiotics 
for its treatment.  
 
MATERIALS AND METHODS 
  The undertaken study conducted in the 
Department of Microbiology, TUTH, Kathman-
du, Nepal from 1st April 2017 to 30th Septem-
ber 2017. Total 155 patients, aged between 25
-50 years, with culture-positive UTI, were in-
volved. The causative organisms isolated in 
culture and their antibiotic sensitivity pattern 
was retrospectively studied.  
           Mid-stream urine samples collected 
from the patients with urinary control and cath-
eter samples collected from those without uri-
nary control. Urine microscopy along with cul-
ture and antibiotic sensitivity performed in the 
lab of TUTH.  Kirby-Bauer disk diffusion meth-
od was used for Antibiotic Susceptibility Test. 
Nitrofurantoin, amikacin, norfloxacin, levofloxa-
cin, cotrimoxazole, cefixime, ceftriaxone, 
ceftazidime, cephalexin, gentamycin, amoxicil-
lin and cloxacillin were tested as first-line anti-
biotics whereas Imipenem, polymyxin-B, col-
istin-sulfate, chloramphenicol, tigecycline, pip-
eracillin, piperacillin-tazobactam, cefopera-
zone, cefoperazone-sulbactam, ampicillin-
sulbactam, cefepime, vancomycin, teicoplanin, 
clindamycin, tobramycin, and amoxicillin-
clavulanic acid taken as second-line antibiot-
ics. Zone of inhibition was measured and clas-
sified as sensitive, intermediate and resistant 
strains. Those organisms which were resistant 
to at least 3 or > 3 groups of antibiotics were 
considered as MDR ( Magiorakos et al., 2012). 
ESBL Detection: For the detection of 
ESBL, disk diffusion method used. Microbes 
were inoculated in Mueller-Hinton agar with 
antibiotic concentration of ceftazidime 30 mi-
crogram(μg)/ceftazidime-clavulanate 
30μg/10μg and cefotaxime 30μg/cefotaxime-
clavulanate 30μg/10μg and incubated for 16-
20 hours in 35°C ± 2°C; ambient air. ESBL 
considered when a ≥ 5-mm increase in a zone 
diameter for either antimicrobial agent tested 
in combination with clavulanate vs. the zone 
diameter of the agent when tested alone 
(CLSI., 2007). 
  MBL Detection: Combination disk dif-
fusion method implemented. Microbes were 
inoculated onto Mueller-Hinton agar using two 
imipenem 10μg disks, one with 292μg EDTA 
placed 25mm apart. An increase in zone diam-
eter of >4 mm around the Imipenem-EDTA 
disk compared to that of the Imipenem disk 
alone was considered positive for an MBL 
(Franklin et al., 2006). 
MRSA Detection: Disk diffusion 
method used. Staphylococcus were inoculated 
onto Mueller-Hinton agar with cefoxitin 30μg 
disk and incubated for 16-18 hours in tempera-
ture 33°C-35°C. MRSA positive reported if the 
zone of inhibition was ≤ 21mm (CLSI., 2007). 
 
Culture Positive Criteria:  
Conduction of the study approved from ethics 
and research committee of TUTH. Data’s were 
recorded in a self-designed form and statically 
evaluated using Microsoft Excel 2016.  
 
RESULTS AND DISCUSSION 
 Total of 155 culture positive cases, fe-
males were more affected with UTI (n=114, 
73.5%) than males (n=41, 26.5%) (Figure 1). 
Gram-negative bacteria were the main cause 
of UTI (73%). Major gram-negative bacteria 
isolated was E. coli (53%) followed by 
Klebsiella pneumonia (7%), Pseudomonas ae-
ruginosa (3%). Gram-positive organism com-
prises 27% of which major isolation was of En-
terococcus faecalis (13%) followed by Staphy-
lococcus aureus (11%.) and Staphylococcus 
saprophyticus (3%) (Figure 2). 
Figure 1. Gender classification of patients.  
Route of collection Colony Count 
Supra Pubic Aspira-
tions 
Urinary pathogens in 
any number 
Urethral catheter 
sample 
>=50x103 CFU/ml 
Mid-stream sample >105 CFU/ml 
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Majority of the micro-organisms isolated in 
culture were Multi-Drug Resistant (MDR) 
(51.94%) (Figure3). Among staphylococcus 
aureus, MRSA (21.41%) were isolated (Figure 
4). Resistant to the major first-line antibiotics 
has observed. Gram-negative bacteria were 
found to be more sensitive to Polymyxin B, 
Colistin Sulphate except Burkholderia Cepa-
cian followed by Imipenem, Amikacin, 
Levofloxacin, Nitrofurantoin whereas Tigecy-
cline was found to be 100% sensitive. Gram-
positive isolates were most sensitive to Van-
comycin, Tigecycline, Teicoplanin followed by 
Gentamycin, levofloxacin, and Nitrofurantoin. 
All MDR bacterial isolates were 100% sensi-
tive to Tigecycline (Table 1). The high figure 
of ESBL (33.92%) and MBL (3.57%) observed 
among Gram-negative isolates (Figure 5).  
 
Figure 3. Percentage of multi drug resistant 
organism’s growth on culture and sensitivity  
 
Figure 4. Percentage of Methicillin Resistant  
Staphylococcus Aureus (MRSA) 
Figure 5. Percentage of Extended Spectrum β
-lactamase (ESBL) and Metallo β-lactamase 
(MBL) among Gram negative isolates  
Figure 2. Pie-chart showing number and percentage of causative agents of UTI. 
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Table 1. Sensitivity of the Micro-Organisms with first-line and second- line antibiotics  
Antibiotics 
  
Causative Micro-Organisms 
  Escherich-
ia coli 
(n=83) 
Entero-
coccus 
faecalis 
(n=20) 
  
Staphylo-
coccus 
aureus 
(n=17) 
  
Klebsiella 
pneumoni-
ae 
(n=11) 
Pseudo-
monas 
aeruginosa 
(n=5) 
Proteus sp 
(n=4) 
Amoxicillin Sensitive 3 13 2 0   0 
Resistant 80 7 15 11   4 
Cefixime Sensitive 32     6   4 
Resistant 51     5   0 
Cephalexin Sensitive 7   10 3   1 
Resistant 76   7 8   3 
Ceftazidime Sensitive 36     6 2 4 
Resistant 47     5 3 0 
Ceftriaxone Sensitive 36     6   4 
Resistant 47     5   0 
Cefoperazone 
  
Sensitive 0     0 0   
Resistant 83     11 5   
Cefepime Sensitive 10     2 2   
Resistant 73     9 3   
Cefoperazone+ 
Sulbactam 
Sensitive 25     4 3   
Resistant 58     7 2   
Cotrimoxazole Sensitive 38   13 6   1 
Resistant 45   4 5   3 
Levofloxacin Sensitive 48 6 16 7 3 3 
Resistant 35 14 1 4 2 1 
Norfloxacin Sensitive 37 6 12 6 2 3 
Resistant 46 14 5 5 3 1 
Amikacin Sensitive 75     10   4 
Resistant 8     1   0 
Nitrofurantoin Sensitive 75   16 3   0 
Resistant 8   1 8   4 
Ampicillin+ 
Sulbactam 
Sensitive 7     0     
Resistant 76     11     
Piperacillin+ 
Tazobactam 
Sensitive 27     7 3   
Resistant 56     4 2   
Piperacillin Sensitive 0     0 0   
Resistant 83     11 5   
Tigecycline Sensitive 83 20 17 11     
Resistant 0 0 0 0     
Chlorampheni-
col 
Sensitive 73     7     
Resistant 10     4     
Colistin sul-
phate 
Sensitive 81     11 5   
Resistant 2     0 0   
Polymyxin B Sensitive 83     11 5 4 
Resistant 0     0 0 0 
Imipenem Sensitive 75     10 4   
Resistant 8     1 1   
Vancomycin Sensitive   20 17       
Resistant   0 0       
Doxycycline Sensitive   18         
Resistant   2         
Teicoplanin Sensitive   20 15       
Resistant   0 2       
Gentamycin Sensitive     17   4   
Resistant     0   1   
Cloxacillin Sensitive     11       
Resistant     6       
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 In our study, gram-negative bacteria 
(80.3%) were the major cause of UTI. E. coli 
isolated  in (53%) followed by Enterococcus 
faecalis (13%), Staphylococcus aureus (11%), 
Klebsiella pneumonia (7%). A study done by 
(Joshi et al., 2016) found E. coli (66.7%) fol-
lowed by Enterococcus (7.55%) and Staphylo-
coccus (6.60%) causing UTI. This study was 
similar to our study by the prevalence of major 
uropathogens, but variation in percentage 
might be due to different places of studies. In 
another study by (Acharya et al., 2011), E. coli 
(68.77%) was a major pathogen of UTI fol-
lowed by Enterococcus (13.92%) which was 
nearly equal to the percentage as found in our 
study Enterococcus (13%). 
        The study undertaken showed the high 
prevalence of MDR strains (51.94%) in UTI 
causing microbes. Similar results of high prev-
alence of MDR were seen in other studies 
(Baral et al., 2012; Ali et al., 2016) of 41.1% 
and 59% respectively. In another study by 
(Niranjan et al., 2014) most of the isolates in 
urine culture were sensitive to amikacin 
(82.6%), piperacillin-tazobactam (78.2%), ni-
trofurantoin (82.1%) and imipenem (98.9%) 
and sensitivity to ampicillin, cefuroxime, ceftri-
axone, norfloxacin, ciprofloxacin varied be-
tween 11%-25%. The study was comparable 
to our study on regard to the pattern of antibi-
otic sensitivity. Our study also reveled most of 
the isolated causative microbes of UTI were 
sensitive to imipenem, amikacin, nitrofurantoin, 
piperacillin-tazobactam and developed re-
sistant to ampicillin, ceftriaxone, and norfloxa-
cin. 
           The most common cause of UTI was E. 
coli. All thepathogens were sensitive to tigecy-
cline. Gram-negative bacteria were sensitive 
towards polymyxin-B, amikacin, imipenem, ni-
trofurantoin, and norfloxacin whereas gram-
positive were sensitive for vancomycin, gen-
tamycin, levofloxacin, and nitrofurantoin. A na-
tional wise review on the protocol for empirical 
treatment of UTI observed due to the trend of 
developing resistant to commonly used antibi-
otics.  
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